Table 2. Lipid- and glucose-metabolism of blood analysis in 4 experimental groups at 18 weeks of age.

	Parameters	CONT	CONT + HFC	SHRSP5	SHRSP5 + HFC
Lipid-metabolism	HDL-cholesterol, mg/dL	25.0 ± 0.8	37.0 ± 2.3*	16.8 ± 0.8*†	28.8 ± 0.9†‡
	LDL-cholesterol, mg/dL	14.0 ± 0.9	64.7 ± 23.5*	5.4 ± 0.5*†	104.6 ± 13.8*†‡
	Triglyceride, mg/dL	29.2 ± 1.1	52.3 ± 18.4	42.0 ± 5.8	32.8 ± 4.1
	Free fatty acids, µEq/L	567.8 ± 25.2	421.7 ± 55.8	689.4 ± 120.5	518.8 ± 73.3
	LDL- / HDL- cholesterol ratio	0.56 ± 0.03	1.81 ± 0.75*	0.32 ± 0.02†	3.70 ± 0.60*†‡
Glucose-metabolism	Area under curve in OGTT, mg/dL*min*1000	17.3 ± 0.7	17.1 ± 0.7	18.0 ± 1.1	17.3 ± 1.6
	Area under curve in ITT, mg/dL*min*1000	5.2 ± 0.7	5.6 ± 0.2	4.9 ± 0.3	5.0 ± 0.4
	Fasting serum glucose, mg/dL	162.4 ± 6.0	147.3 ± 1.5	166.0 ± 12.5	125.0 ± 5.1

All data are means ± SE; n = 5 in each group.

^*P < 0.05 vs. the CONT group,

^†P < 0.05 vs. the CONT + HFC group,

^‡P < 0.05 vs. the SHRSP5 group.

HDL; high-density lipoprotein, LDL; low-density lipoprotein, OGTT; oral glucose tolerance test, and ITT; insulin tolerance test.